Related references
Note: Only part of the references are listed.Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review
Alain Lescoat et al.
RHEUMATOLOGY (2022)
Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants
Nina M. van Leeuwen et al.
RHEUMATOLOGY (2021)
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes
Alain Lescoat et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2021)
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database
Yannick Allanore et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group
Veronika K. Jaeger et al.
RHEUMATOLOGY (2018)
The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study
Melanie Racine et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2016)
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis
Jessica Meijs et al.
RMD OPEN (2016)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Imatinib in Active Diffuse Cutaneous Systemic Sclerosis: Results of a Six-Month, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Pilot Study at a Single Center
Janet Pope et al.
ARTHRITIS AND RHEUMATISM (2011)
Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey
Marielle Bassel et al.
RHEUMATOLOGY (2011)
Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis
L. Mouthon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The Minimally Important Difference in Clinical Practice for Patient-centered Outcomes Including Health Assessment Questionnaire, Fatigue, Pain, Sleep, Global Visual Analog Scale, and SF-36 in Scleroderma
Suneet Sekhon et al.
JOURNAL OF RHEUMATOLOGY (2010)
The Minimally Important Difference for the Health Assessment Questionnaire in Rheumatoid Arthritis Clinical Practice Is Smaller Than in Randomized Controlled Trials
Janet E. Pope et al.
JOURNAL OF RHEUMATOLOGY (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Development of a provisional core set of response measures for clinical trials of systemic sclerosis
D. Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Assessing disability and quality of life in systemic sclerosis:: Construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), systemic sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey
Francois Rannou et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
The Health Assessment Questionnaire Disability Index and Scleroderma Health Assessment Questionnaire in Scleroderma Trials: An evaluation of their measurement properties
SR Johnson et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis
D Khanna et al.
ARTHRITIS AND RHEUMATISM (2005)
The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma
N Sultan et al.
RHEUMATOLOGY (2004)
Share Paper
